Menü
sharewise sharewise
Einloggen
Registrieren
Einloggen
Registrieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von HC Wainwright 

Applied DNA Sciences Inc. diskutieren

Applied DNA Sciences Inc.

WKN: A2PUTA / Symbol: APDN / Name: Applied DNA / Aktie / Chemie / Micro Cap /

0,23 €
-11,48 %

5 0
5
0
Einschätzung Buy
Rendite (%) -56,30 %
Kursziel 4,59
Veränderung
Endet am 23.03.24

Applied DNA Sciences, Inc. (NASDAQ: APDN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Ratings data for APDN provided by MarketBeat

HC Wainwright 
0
Melden Teilen
23.03.23
Einschätzung Buy
Rendite (%) -60,42 %
Kursziel 4,59
Veränderung
Endet am 31.03.24

Applied DNA Sciences, Inc. (NASDAQ: APDN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Ratings data for APDN provided by MarketBeat

HC Wainwright 
0
Melden Teilen
31.03.23
Einschätzung Buy
Rendite (%) -80,49 %
Kursziel 4,45
Veränderung
Endet am 14.07.24

Applied DNA Sciences, Inc. (NASDAQ: APDN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Ratings data for APDN provided by MarketBeat

HC Wainwright 
0
Melden Teilen
14.07.23
Einschätzung Buy
Rendite (%) -82,93 %
Kursziel 3,70
Veränderung
Endet am 24.08.24

Applied DNA Sciences, Inc. (NASDAQ: APDN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Ratings data for APDN provided by MarketBeat

HC Wainwright 
0
Melden Teilen
24.08.23
Einschätzung Buy
Rendite (%) -73,57 %
Kursziel 1,86
Veränderung
Endet am 08.12.24

Applied DNA Sciences, Inc. (NASDAQ: APDN) had its price target lowered by analysts at HC Wainwright from $4.00 to $2.00. They now have a "buy" rating on the stock.
Ratings data for APDN provided by MarketBeat

HC Wainwright 
0
Melden Teilen
08.12.23
Einschätzung Buy
Rendite (%) -57,67 %
Kursziel 1,39
Veränderung
Endet am 09.02.25

Applied DNA Sciences, Inc. (NASDAQ: APDN) had its price target lowered by analysts at HC Wainwright from $2.00 to $1.50. They now have a "buy" rating on the stock.
Ratings data for APDN provided by MarketBeat

HC Wainwright 
0
Melden Teilen
09.02.24
Noch kein Mitglied? Jetzt kostenlos registrieren!

Neueste Beiträge

HC_Wainwright in Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its "b...
09.05.24
Citigroup_Inc_ in Angie's List Inc. diskutieren
Angi Inc. (NASDAQ: ANGI) had its price target lowered by ...
09.05.24
Needham___Company_LL in Gilat Satellite Networks Ltd. diskutieren
Gilat Satellite Networks Ltd. (NASDAQ: GILT) had its "bu...
09.05.24
Citigroup_Inc_ in Trade Desk Inc diskutieren
The Trade Desk, Inc. (NASDAQ: TTD) had its price target r...
09.05.24
HC_Wainwright in Prothena Corp. plc diskutieren
Prothena Co. plc (NASDAQ: PRTA) had its price target lowe...
09.05.24
Needham___Company_LL in Audiocodes Ltd. diskutieren, AudioCodes Ltd.
AudioCodes Ltd. (NASDAQ: AUDC) had its price target lower...
09.05.24
TD_Securities in Enerplus Corp. diskutieren
Enerplus Co. (NYSE: ERF) had its price target raised by a...
09.05.24
Royal_Bank_of_Canada in Quidel Corp. diskutieren, QuidelOrtho Corp.
QuidelOrtho Co. (NASDAQ: QDEL) had its price target lower...
09.05.24
Mehr anzeigen